Organon (NYSE: OGN) reported Q3 EPS of $1.32, $0.15 better than the analyst estimate of $1.17. Revenue for the quarter came in at $1.54 billion versus the consensus estimate of $1.53 billion.

GUIDANCE:

Organon sees FY2022 revenue of $6.1-6.2 billion, versus the consensus of $6.17 billion. Adjusted EBITDA margin range narrowed and raised to 33.5% to 34.5%.

For earnings history and earnings-related data on Organon (OGN) click here.